Stockscreener 앱 받기
1.66
39.50%
0.47
시간 외 거래:
1.51
-0.15
-9.04%
전일 마감가:
$1.19
열려 있는:
$1.36
하루 거래량:
47.24M
Relative Volume:
63.27
시가총액:
$81.42M
수익:
$134.60K
순이익/손실:
$-11.81M
주가수익비율:
-6.8908
EPS:
-0.2409
순현금흐름:
$-10.05M
1주 성능:
+34.96%
1개월 성능:
+30.71%
6개월 성능:
+9.21%
1년 성능:
-1.19%
1일 변동 폭
$1.20
$1.96
1주일 범위
$1.168
$1.96
52주 변동 폭
$1.13
$2.55
Medicinova Inc Stock (MNOV) Company Profile
명칭
Medicinova Inc
전화
858-373-1500
주소
4275 EXECUTIVE SQUARE, LA JOLLA, CA
MNOV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MNOV
Medicinova Inc
|
1.66 | 58.37M | 134.60K | -11.81M | -10.05M | -0.2409 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Medicinova Inc Stock (MNOV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-03-10 | 개시 | Maxim Group | Buy |
| 2019-03-25 | 재개 | B. Riley FBR | Buy |
| 2018-03-28 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-04-18 | 개시 | Credit Suisse | Outperform |
| 2013-01-04 | 재확인 | Ladenburg Thalmann | Buy |
| 2012-05-24 | 다운그레이드 | MLV & Co | Buy → Hold |
| 2011-10-18 | 재확인 | MLV Capital | Buy |
| 2011-06-22 | 개시 | Global Hunter Securities | Buy |
| 2010-05-12 | 개시 | Wedbush | Outperform |
| 2008-11-12 | 재확인 | Ladenburg Thalmann | Buy |
| 2008-05-15 | 개시 | Rodman & Renshaw | Mkt Outperform |
| 2007-07-09 | 개시 | Punk, Ziegel & Co | Buy |
모두보기
Medicinova Inc 주식(MNOV)의 최신 뉴스
What dividend safety score for MediciNova Inc. stockTrend Reversal & Reliable Trade Execution Plans - newser.com
Market reaction to MediciNova Inc.’s recent newsJuly 2025 Gainers & Safe Entry Trade Signal Reports - newser.com
MediciNova Research Sparks New Hope for Atherosclerosis Therapy - StocksToTrade
MediciNova’s Breakthrough Strategy in Atherosclerosis Treatment - timothysykes.com
Applying big data sentiment scoring on MediciNova Inc.Earnings Risk Summary & Safe Entry Zone Tips - newser.com
Developing predictive dashboards with MediciNova Inc. dataGap Up & Low Risk High Win Rate Stock Picks - newser.com
MediciNova, Inc. (MNOV) Stock Price, News, Quote & History - Yahoo! Finance Canada
Will MediciNova Inc. stock benefit from infrastructure spendingJuly 2025 EndofMonth & Verified Technical Signals - newser.com
MediciNova Advances Atherosclerosis Research with Novel Therapeutic Strategy - StocksToTrade
MediciNova’s New Research Drives Strategic Focus on Cholesterol Metabolism - timothysykes.com
MediciNova compounds demonstrate novel therapeutic approach for Atherosclerosis - Yahoo Finance
MediciNova Stock Surge: Unveiling the Latest Development - timothysykes.com
MediciNova (MNOV) Analyst Ratings: Consistent 'Buy' Rating Maint - GuruFocus
D. Boral Capital Maintains MediciNova (MNOV) Buy Recommendation - Nasdaq
MediciNova Stock Rockets 85% After-Hours On Promising Heart Study — Traders Hope For ‘Big Green Candle’ - Stocktwits
Key resistance and support levels for MediciNova Inc.Portfolio Growth Summary & Intraday High Probability Setup Alerts - newser.com
Will MediciNova Inc. stock remain a Wall Street favoriteBull Run & Daily Risk Controlled Trade Plans - newser.com
Why Did MediciNova Stock (MNOV) Jump Over 87% In After-Hours Trading? - Benzinga
MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in ... - Enidnews.com
MediciNova, Inc. Publishes Research on MN-002's Potential in Atherosclerosis Treatment in Journal of Atherosclerosis and Thrombosis - Quiver Quantitative
MediciNova (NASDAQ: MNOV) publishes tipelukast data: MN-002 enhances cholesterol efflux - Stock Titan
RMN.BE interactive stock chart | Medicinova Inc. R stock - Yahoo! Finance Singapore
Why MediciNova Inc. stock could see breakout soonQuarterly Trade Summary & Expert Curated Trade Setups - fcp.pa.gov.br
MediciNova Inc Stock Analysis and ForecastInterest Rate Changes & Stay Ahead With Daily Market Discussions - earlytimes.in
Medicinova Inc (MNOV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.62%
0.21%
자본화:
|
볼륨(24시간):